Vancouver, British Columbia--(Newsfile Corp. - May 21, 2025) - NervGen Pharma Corp. (NGEN:CA) (OTCQB: NGENF), a clinical-stage biotechnology company dedicated to developing neuroreparative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results